e-learning
resources
London 2016
Tuesday, 06.09.2016
Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A post-hoc analysis of donor lungs declined for transplantation
Stijn Verleden (Leuven, Belgium), Stijn Verleden, An Martens, Tobias Heigl, Hannelore Bellon, Elly Vandermeulen, Robin Vos, Johny Verschakelen, Walter Coudyzer, Dirk Van Raemdonck, Arne Neyrinck, Bart Vanaudenaerde
Source:
International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Session:
Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Session type:
Oral Presentation
Number:
3337
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stijn Verleden (Leuven, Belgium), Stijn Verleden, An Martens, Tobias Heigl, Hannelore Bellon, Elly Vandermeulen, Robin Vos, Johny Verschakelen, Walter Coudyzer, Dirk Van Raemdonck, Arne Neyrinck, Bart Vanaudenaerde. A post-hoc analysis of donor lungs declined for transplantation. Eur Respir J 2016; 48: Suppl. 60, 3337
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Pulmonary function tests in pre and post transplant follow-up of bone marrow transplant patients
Source: Annual Congress 2010 - Advances in lung function II
Year: 2010
Improvements in lung function with umeclidinium/vilanterol analysed by reversibility at screening: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Alternatives to lung donor shortage
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=89
Year: 2004
Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017
A descriptive analysis of exercise capacity before and after solid organ transplant
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008
Exercise capacity after lung transplantation: analysis by gender, diagnosis and transplant characteristics
Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies
Year: 2019
Structural differences in airways during chronic rejection after lung transplantation: A (micro)-CT analysis
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012
Association between tacrolimus levels in the first fifteen days post lung transplant and rejection during the first year
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Impact of donor, recipient and matching on survival after high emergency lung transplantation in France
Source: Eur Respir J, 54 (5) 1900096; 10.1183/13993003.00096-2019
Year: 2019
Strategies to increase limited donor resources
Source: Eur Respir J 2004; 23: 477-482
Year: 2004
3
He-MRI in lung transplant recipients (LTR) in correlation with lung function tests
Source: Eur Respir J 2001; 18: Suppl. 33, 179s
Year: 2001
The prospective estimation of pulmonary function's test and diffusive capacity in patients after autologus bone marrow transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 349s
Year: 2002
Challenges in post transplant lung pathology
Source: School Course 2012 - Lung Transplantation
Year: 2012
Do DCD donor lung transplants perform well?
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Multiple breath washout testing after paediatric blood and marrow transplantation
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
A UK centre based review of tuberculosis post kidney transplantation
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Treatment options in chronic GVHD and CLAD post lung transplantation
Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities
Year: 2016
Predictive value of donor age for recipient lung function and CLAD-free survival after lung transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Living-donor lobar transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=257
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept